Crossmark

Fetal hemoglobin-boosting haplotypes of BCL11A gene and HBS1L-MYB intergenic region in the prediction of clinical and hematological outcomes in a cohort of children with sickle cell anemia

Crossref DOI link: https://doi.org/10.1038/s10038-022-01079-0

Published Online: 2022-09-27

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sales, Rahyssa Rodrigues

Nogueira, Bárbara Lisboa

Belisário, André Rolim

Faria, Gabriela

Mendes, Fabiola

Viana, Marcos Borato

Luizon, Marcelo Rizzatti https://orcid.org/0000-0002-8331-3525
Funding

Funding for this research was provided by:

Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Científico e Tecnológico (312599/2019-6)

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Finance Code 001, Finance Code 001)
License Information

Text and Data Mining valid from 2022-09-27

Version of Record valid from 2022-09-27
More Information

Article History

Received: 6 April 2022

Revised: 24 August 2022

Accepted: 24 August 2022

First Online: 27 September 2022

Competing interests

: The authors declared no competing interests.

Document is current

Any future updates will be listed below